APT Medical

APT Medical EBITDA per Share

The EBITDA per Share of APT Medical (688617.SS) as of Oct 14, 2026 is 6.70 CNY. In the previous year, EBITDA per Share was 5.75 CNY — a change of 16.48% (higher).

EBITDA per Share

6.70CNY

YoY

16.48%

Last updated:

EBITDA per Share of APT Medical is 2025 6.70 CNY. EBITDA per Share of APT Medical was 2024 5.75 CNY. It decreases by 16.48% higher compared to the previous year.

The APT Medical EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.21 CNY
Jan 1, 2019
0.95 CNY
Jan 1, 2020
1.24 CNY
Jan 1, 2021
1.70 CNY
Jan 1, 2022
3.01 CNY
Jan 1, 2023
4.54 CNY
Jan 1, 2024
5.75 CNY
Jan 1, 2025
6.70 CNY
The APT Medical EBITDA per Share history
YEAREBITDA per ShareYoY
6.70CNY+16.48%
5.75CNY+26.73%
4.54CNY+50.51%
3.01CNY+77.54%
1.70CNY+36.40%
1.24CNY+30.53%
0.95CNY+363.44%
0.21CNY-18.12%
0.25CNY—
Access this data via the Eulerpool API
Get Free API Key

APT Medical Stock analysis

What does APT Medical do? APT Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about APT Medical stock

EBITDA per Share of APT Medical is 6.70 CNY in 2025.

EBITDA per Share of APT Medical changed from 5.75 CNY to 6.70 CNY, representing a 16.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share APT Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — APT Medical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — APT Medical